SOLI about to come off greys huge merger with

New Post Public Reply Private Reply Replies (1) Message Board
wayno2 budfoxfun #91771
620
SOLI about to come off greys huge merger with KBMedical/CareClix https://careclix.com/ So lemme Break this down for you. It’s really cut and dry. No long twisting roads etc...

1.) Back in October of 2017 SOLI put out some filings to get current as a Pink Sheet no filer. Listed in those filings was Mr Scott and Mr Joshua Flood had purchased the dead Grey sheet stock Solei Systems SOLI shell.

https://backend.otcmarkets.com/otcapi/company...40/content

2.) Mr Flood and Mr Scott Merged into the SOLI shell. Their company called. Clinical & Herbal Innovations in a one for one stock exchange. It was Executed on Oct 20th 2017. Clinical Herbal sells Panaxol. A supplemental for opening the Air Ways to Blood Vessels etc...

http://www.panoxol.com/

3.) CHI became a Subsidiary of SOLI with Patents etc owned by Mr Scott leased to SOLI (details are in the November 26th 10-12G/A if you fast forward for answers on the Patent.

https://www.sec.gov/Archives/edgar/data/17503...ex10_3.htm

4.) After that. SOLI Essentially went dead quiet. threewheeler and I essentially we’re stuck and just waiting with dead gray market shares in our brokerage accounts.

5.) Out of the Blue on 9-24-2018 almost a Year Later SOLI Filed their Form 10 (10-12G).

https://www.sec.gov/cgi-bin/browse-edgar?CIK=...getcompany


6.) SOLI wasn’t even connected to OTC Markets or IHUB Sec wire and I had no idea that filing even came out until one evening if I recall threeWheeler saw it and posted it to me on IHub. I actually contacted OTC Markets myself and IHub asking them to fix the SEC link problem. Which they did as you can see.

7.) In the Form 10 it listed that in June of 2017 Mr Scott our CEO Purchased controlling interest from the ex CEO Mr Paul Spivak in a Private Transaction. Page 1 of the Form 10 under History.

Quote:
The company (SOLI) has been trading on the grey market since February 2014. In June 2017 the control block of SOLI was purchased by Charles Scott from Paul Spivak in private sale, at which time the old company management was removed, and new management put in place.


https://www.sec.gov/Archives/edgar/data/17503...-1012g.htm

8.) Once that transaction took place all previous management was removed and new management put in place.

https://www.sec.gov/Archives/edgar/data/17503...-1012g.htm

9.) On November 6th, November 26th and Dec 13th Amendments came out in the Form 10 tweaking a few things here and there. Like the Patent info of Panaxol etc... Small stuff.

https://www.sec.gov/cgi-bin/browse-edgar?CIK=...getcompany

10.) In the last Amendment 10-12G/A on 12-13-2018 under description of business I noticed a small Paragraph that said they plan to raise the necessary funds and make an acquisition in the healthcare market. (It also mentions it in the other amendments I just never noticed) Page 1

Quote:
Within the next six months, we intend to raise capital necessary to operate the business. We plan to grow revenue through the sale of our dietary supplement as well as mergers and acquisitions of health companies. We will begin searching to acquire a telemedicine company as soon as feasible.


https://www.sec.gov/Archives/edgar/data/17503...-1012g.htm

11.) On Jan 15th 2019 the 8k came out of no where regarding the Soli acquisition of CareClix. It was a LOI and a DD period ending in Jan 31st per the 8k and if all parties agreed we would go to close.

https://www.sec.gov/Archives/edgar/data/17503...-index.htm

12.) On February 26th the Binding LOI was signed as definite binding agreement and the 8k came out confirming both Parties has Signed and Agreed to go to Close on April 15th. Per the agreement in the 8k the Share Structure was to be untouched as it has been. Float 49 mill OS 116 mill Mr Scott owns 64 mill Restricted.

https://www.sec.gov/Archives/edgar/data/17503...-index.htm

13.) On March 15th A Form D hits for basically Friends and Family and Big investors to raise 3 mill. In the Form D it specifically states 1 mill will go to CareClix for the closing of the Acquisition.

https://www.sec.gov/Archives/edgar/data/17503...-index.htm

Quote:
We will use $1,000,000 of this to complete the acquisition of assets of KB Medical Systems as described in the Form 8-K filed with the SEC, dated February 26, 2019.


14.) Per the Feb 8k SOLI will have been admitted to trading on Pink Sheets or am equivalent Exchange prior to or at Closing.

Quote:
a) Seller shall have obtained the $1,000,000 cash consideration portion of the Consideration as provided herein and the common shares of SOLI shall be admitted for trading on the OTC Markets Pink Sheets or such other equivalent trading market as Buyer and Seller shall mutually agree at or prior to Closing.


https://www.sec.gov/Archives/edgar/data/17503...252019.htm


On a Side note. Mr Scott has Known Mr Korangy for many years. Its out there in the public eye. Mr Budhrani is so well recognized and also runs Innovation Health. Mr Budhrani is the founder of CareClix

Quote:
FALLS CHURCH, Va., March 6, 2019 /PRNewswire/ -- Innovation Health has named Sunil BudhraniMD, MPH, MBA, as the new Chief Executive Officer (CEO) of Innovation Health. Budhrani served as the Chief Medical Officer (CMO) for Innovation Health for the last three years and will continue in the role, while also serving as CEO.


https://www.prnewswire.com/news-releases/dr-s...07753.html


SOLI is staying SOLI and CareClix is staying CareClix as a Subsidiary of SOLI and operating business as usual. CareClix Management is receiving employee contracts etc.. Which will probably has stock options like Big Boards etc..

Quote:
John Korangy and Simon Kim shall have received an employment agreement (“Employment Agreement”) from Buyer in a form satisfactory to the terms as set forth in those certain letter agreements dated February 20, 2019 between Buyer and Korangy, Buyer and Kim.


https://www.sec.gov/Archives/edgar/data/17503...252019.htm


Per the Form D a new BOD will he created as well.

Quote:
We may replenish line of credit taken out by Charles Scott and we may begin a salary for Charles Scott, but that decision will be made by the Board in the future after the compensation committee has been established.


https://www.sec.gov/Archives/edgar/data/17503...ry_doc.xml




Lastly and it’s totally my opinion only. To answer your last question. YES it’s only a handful of people that know this Acquisition is taking place. Us here on IHub and insiders only. It’s my opinion that the relationship Mr Scott has with Mr Korangy made it easy to make the decision to go public via SOLI and not the long expensive drawn out way onto the big boards directly. I belieber SOLI will turn into a conglomerate like TDOC and we will be making many more Acquisitions over the coming years.

We have a very rare opportunity here and I hope this answers all of your questions and explains the time line properly. TDOC is a Billion dollar company that is experiencing massive growth and CareClix is following its exact foot steps. CareClix is affiliated with and has so much exposure I cannot even list them all here and is even opening up over seas in Dubai etc... John Hopkins is involved. Aetna, GE Healthcare, Verizon and so many more.

https://careclix.com/

Hope this helps and answers all your questions.


Regards

Smitter
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Midterm Election Insights: Border Enforcement Debate Heats Up

Updated Category News Views 153

The Midterm Aftermath: What Really Matters So the ballots are counted, and once again, the shiny chatter about midterms seemed to orbit more around wallet aches and foreign skirmishes than dusty border control debates. But, dig a bit deeper—like poking at a sore spot—and you'll find border security sitting patiently in the wings. Not gone, just waiting for its...

Continue Reading
Cognex Delivers Record Q3 Results, Eyes Future Growth

Updated Category News Views 107

Shaking Up the Leaderboard with Record Revenues You want a testament to a well-oiled machine? Look no further than Cognex Corporation, flaunting a record quarterly revenue hitting $313 million. That's a hearty 13% uptick from last year. Peel back the layers, and excluding a one-time boon from a partnership last year, you're staring at a 19% year-over-year surge. Talk...

Continue Reading
Breeze Airways Secures $228M for Fleet Expansion

Updated Category News Views 58

Breeze Airways and AIP's Milestone Deal Just as the ink is drying on the balance sheets, Breeze Airways is busy making significant moves in the aviation game. Partnering with AIP Capital, they just locked in a $228 million secured debt facility to grab six new Airbus A220-300 aircraft. Now, that’s how you stake your claim in the market. What we’ve got here isn’t...

Continue Reading
NIH Seeks AI Solutions for Kidney Disease Breakthroughs

Updated Category News Views 83

A Cosmic Approach to Kidney Disease When you think about celestial wonders captured by telescopes, the last thing that probably comes to mind is kidney disease. Yet, here we are—with the National Institutes of Health (NIH) issuing a peculiar call to arms: apply astronomy's AI methods to unveil patterns in kidney disease data. It's the kind of inspired lunacy that could...

Continue Reading
Cooper Standard Faces Challenges Despite New Business Wins

Updated Category News Views 156

Cooper Standard's Balancing Act Alright, let’s cut straight to the chase. Cooper Standard (NYSE: CPS) finds itself dabbling in a tricky dance—juggling sparkling new business awards while grappling with stubborn inflationary headwinds and a kick to the shin from production volume shortfalls. Third quarter of 2026, and they reported net new business awards worth a hefty...

Continue Reading
Truelink's Strategic Expansion: GES Acquires CSG Creative

Updated Category News Views 31

Truelink's Big Move in Creative Marketing I don't throw around the word 'synergy' lightly, but this Truelink Capital move has me grudgingly utter it. Picture this: GES, a big dog in event marketing, just grabbed CSG Creative, a firm with its teeth sunk deep into association and event organizer marketing. It sounds like the kind of match you only find lurking in the fancy...

Continue Reading
PSG's Anna AI Wins Vizient's Innovative Tech Nod

Updated Category News Views 79

Hospital Hiring Gets a Tech Boost In the bustling world of healthcare recruitment, it's like trudging through quicksand with a time bomb strapped to your back. That's where PSG Global Solutions sauntered into the Las Vegas spotlight with Anna AI, their generative AI marvel that just snagged the Innovative Technology designation from Vizient. This ain’t your...

Continue Reading
Cogent's Q3 2026: A Mixed Bag of Financial Moves

Updated Category News Views 110

Cogent Communications' Latest Quarter Insights When you hitch your wagon to the communications and internet industry, there's no escaping the hard truths from meticulous quarterly reports. Take Cogent Communications' latest Q3 2026 results, where numbers speak louder than words. Service revenue dipped to $231.2 million for the quarter, a 1.8% drop compared to Q2. And...

Continue Reading
Fosun's Strategic Innovations Unveiled at CIIE 2026

Updated Category News Views 108

Fosun's Nine-Year CIIE Journey Fosun's been trotting out its innovations at the China International Import Expo (CIIE) for nine straight years. With 162 countries in the mix this time around, they're not just playing house—it’s downright world-class boasting. Fosun’s rolling out their hard-hitters in the medical tech space, showing they’re no rookies to the...

Continue Reading
Marini SkinSolutions Wins with Night Zyme Complex

Updated Category News Views 89

Shaking Up the Skincare Scene You don't often see a skincare product snag three prestigious awards in one year, but that's exactly what's unfolding for Marini SkinSolutions. This time, their Night Zyme® Overnight Glass Skin Resurfacing Complex grabbed the 2026 Shop TODAY Ageless Beauty Award. It’s turning heads and not just in beauty aisles but among investors eyeing a...

Continue Reading

Top 5 Most Recently Viewed Articles

Boldyn Networks Achieves Major Player Status in Private 5G Market

Updated Category News Views 163

Boldyn Networks Achieves Major Recognition in Private 5G Sector Boldyn Networks, a global leader in private networks and shared communications infrastructure, has made waves in the telecommunications industry with its recent recognition as a Major Player in the IDC MarketScape: European Enterprise Private 5G Solutions 2025 Vendor Assessment. This validation reflects...

Continue Reading
LinkSquares Debuts All-Agentic CLM Platform for Legal Teams

Updated Category News Views 16

LinkSquares: A Game Changer for Contract Management In the world of legal and business operations, few things eat away at patience—let alone profits—like the cumbersome dance of contract management. Enter LinkSquares, strutting onto the stage with its new all-agentic CLM platform, promising to turn this often painful process into a streamlined operation that saves...

Continue Reading
Sanctuary Medicinals Triumphs at NECANN Cup with Recognition

Updated Category News Views 216

Sanctuary Medicinals Shines at NECANN Cup Boston 2025 Sanctuary Medicinals proudly celebrates a remarkable achievement at the 6th Annual NECANN Cup Boston. The company earned the impressive title of 4th place in the competitive Solvent Concentrates category. This accolade showcases Sanctuary Medicinals' unwavering commitment to excellence, innovation, and quality within...

Continue Reading
Patients Continue Obesity Treatments as Coverage Shrinks

Updated Category News Views 174

The Growing Challenge of Obesity Drug Coverage For many individuals battling obesity, the struggle is not just about losing weight. It’s also about bearing the financial burden of treatments. With increasing limitations from insurers regarding weight-loss drugs, patients are often forced to alter their lifestyles significantly. Vacations are postponed, dining out is...

Continue Reading
Humacyte, Inc. Investors Urged to Act Before Class Action Deadline

Updated Category News Views 123

Important Attention for Humacyte, Inc. Investors As an investor in Humacyte, Inc., it’s essential to stay informed about legal opportunities that could impact your investments. The Rosen Law Firm, known for its dedication to protecting investor rights, is reminding those who purchased Humacyte securities during a specified period about an important upcoming deadline....

Continue Reading